Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Revenue

In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B JPY with 0.09% growth. Kobayashi Pharmaceutical had revenue of 53.70B in the quarter ending December 31, 2025, with 5.01% growth.

• Revenue: 165.74B
• Revenue Growth: +0.09%
• P/S Ratio: 2.52
• Revenue / Employee: 45.85M
• Employees: 3,615
• Market Cap: 417.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	165.74B	142.00M	0.09%
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%